US and Iran Signal Potential Progress in Talks but Key Disputes Over Uranium and Strait of Hormuz Tolls Remain DWave Systems Shares Surge 44 After Securing Government Backing for Quantum Computing Initiatives Analyst Report Update SP Global Inc Market Position and Segment Outlook Why Most US Manufacturers Still Arent Using AI and Automation Analysis Ebola Outbreak in Uganda Death Toll Reaches 177 Global Health Stocks and Travel Sector Await Impact Viatris Inc Attracts Analyst Attention Amid Strategic Portfolio Shifts BiomX Inc PHGE Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline RERE Q1 2026 Earnings EPS Surprises by 1832 But Stock Declines 507 Ainos Inc AIMD Q1 2025 Earnings Deepening Losses Amid Operational Challenges UFPI Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower Laureate Education Inc LAUR Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Share Uptick Savara Inc SVRA Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline GPACU Holds Steady at 1009 as SPAC Units Trade in Tight Range VICI Properties VICI Holds Steady Near 2850 as REIT Sector Weighs Macro Headwinds NextNRG Inc NXXT Surges 23 as Renewed Momentum Drives Shares Higher Nexentis Technologies NXTS Surges 154 Momentum Builds Above Key Support Community Trust Bancorp CTBI Slightly Lower as Shares Test Support Levels CARE Q1 2026 Earnings Major EPS Disappointment Belies Surprising Stock Stability ESE Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher SELLAS Life Sciences Group SLS Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Focuses on Pipeline Progress AQB Q3 2024 Earnings Narrowerthanexpected loss drives modest stock gain TISI Q1 2026 Earnings Deep EPS Loss Weighs on Sentiment as Stock Slips GAING Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Falls Short Ethereums SecondPlace Status Under Threat by 2030 Market Watchers Weigh In Voyager Therapeutics Q1 2026 Earnings EPS Beat Masks Strategic Uncertainty as Stock Declines Veracyte Shares Dip as Biotech Sector Faces Headwinds Key Support Tested